An Open-label, Single-dose Study to Determine the Metabolism and Excretion of [14C]E2006 in Healthy Male Subjects
Phase of Trial: Phase I
Latest Information Update: 16 Feb 2015
Price : $35 *
At a glance
- Drugs Lemborexant (Primary)
- Indications Insomnia
- Focus Pharmacokinetics
- Sponsors Eisai Inc
- 15 Jul 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 04 Jun 2014 Planned end date changed from 1 May 2014 to 1 Jun 2014 as reported by ClinicalTrials.gov.
- 18 Apr 2014 According to ClinicalTrials.gov record, status changed from recruiting to active, no longer recruiting.